Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 244,300 | reported | 15 Apr 2021 | tx 13+1,831,406−38,214 |
| Verrica Pharmaceuticals Inc. | 20,000 | reported | 05 Jun 2025 | tx 2+37,502 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jun 2025 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 20,000 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | Verrica Pharmaceuticals Inc. | 17,502 | 0.00 USD | deriv |
| 15 Apr 2021 | GRANT_AWARD | Axovant Sciences Ltd. | 244,300 | 0.00 USD | deriv |
| 17 Mar 2021 | GRANT_AWARD | Axovant Sciences Ltd. | 16,001 | 0.00 USD | |
| 17 Mar 2021 | OTHER | Axovant Sciences Ltd. | 16,001 | 0.00 USD | deriv |
| 12 Jun 2020 | TAX_WITHHOLDING | Axovant Sciences Ltd. | 6,211 | 3.46 USD | |
| 12 Jun 2020 | GRANT_AWARD | Axovant Sciences Ltd. | 16,002 | 0.00 USD | |
| 12 Jun 2020 | OTHER | Axovant Sciences Ltd. | 16,002 | 0.00 USD | deriv |
| 15 Apr 2020 | GRANT_AWARD | Axovant Sciences Ltd. | 42,400 | 0.00 USD | deriv |
| 15 Apr 2020 | GRANT_AWARD | Axovant Sciences Ltd. | 63,700 | 0.00 USD | deriv |
| 21 Sept 2019 | GRANT_AWARD | Axovant Sciences Ltd. | 32,003 | 0.00 USD | deriv |
| 15 Apr 2019 | GRANT_AWARD | Axovant Sciences Ltd. | 767,000 | 0.00 USD | deriv |
| 15 Apr 2019 | GRANT_AWARD | Axovant Sciences Ltd. | 200,000 | 0.00 USD | deriv |
| 16 Jul 2018 | GRANT_AWARD | Axovant Sciences Ltd. | 200,000 | 0.00 USD | deriv |
| 16 Jul 2018 | GRANT_AWARD | Axovant Sciences Ltd. | 250,000 | 0.00 USD | deriv |